Supplier News

The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.

Gallus BioPharmaceuticals, LLC, a biologics contract development and manufacturing organization, and the biopharmaceutical company Omni Bio Pharmaceutical, Inc. have formed a multistage manufacturing services agreement. Omni Bio is focused on...

Agenus Inc.,an immuno-oncology company, has formed a collaboration and license agreement with Merck & Co, for the discovery and development of therapeutic antibodies to immune checkpoints for the treatment of cancer. Under the...

Bristol-Myers Squibb and Samsung Biologics will increase the scope of their existing manufacturing agreement in which Samsung will manufacture commercial drug substances and drug product for several Bristol-Myers Squibb biologic medicines at its...

Cerbios-Pharma SA, based in Lugano, Switzerland, has begun construction of a new building to accommodate R&D (chemical and biological) departments that will include laboratories and related infrastructure. The new building will be...

Catalent Pharma Solutions has signed an agreement with Zhejiang HISUN Pharmaceuticals Co. Ltd. (HISUN), to provide HISUN with a broad range of biosimilar cell lines, using Catalent's proprietary GPEx® technology for the Chinese market. Under...

Aesica, a contract development and manufacturing organization, has successfully introduced serialization services and initiated commercial production of two anti-allergy product lines for the Chinese market at its site in Pianezza  Italy...

AAIPharma, a provider of pharmaceutical analytical testing, product development and manufacturing services, and Cambridge Major Laboratories, a provider of API development and manufacturing services, announce the resignation of Patrick Walsh...